about
Investing in Immunity: Prepandemic Immunization to Combat Future Influenza Pandemics.Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.Modeling optimal age-specific vaccination strategies against pandemic influenza.Disease mongering and the fear of pandemic influenza.An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adultsImmunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.Refining the approach to vaccines against influenza A viruses with pandemic potential.Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferretsVaccinate for the next H2N2 pandemic now.MF59 adjuvant: the best insurance against influenza strain diversity.Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza virusesNatural and long-lasting cellular immune responses against influenza in the M2e-immune host.Vaccination against influenza: role and limitations in pandemic intervention plans.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule.Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines.Emergence of event cascades in inhomogeneous networks.Public health: Life lessons.New approaches to vaccination
P2860
Q30202032-600430B4-1E16-4D33-8F7B-313FBB5568A4Q30205252-5E189A86-FD81-4371-806F-3C2F595BE369Q30224852-67533341-C8E1-46AF-8983-F6A82976AE13Q30226736-E3725D58-E5F3-4CEF-8A2C-5C95763756A2Q30352329-2C60E3F9-7D8D-4E67-AD81-47671A2698ACQ30353708-2F39C128-C597-4D75-9C7D-620C1E2E40CDQ30355688-E3A7322D-632A-4A5E-B0C2-B1746B18DF36Q30365079-84E3C874-B226-4635-A8EA-8FBC8C2A4107Q30368474-B28F23E3-65E9-4958-900F-403709150811Q30373298-4E7562FA-3C1B-4E34-A5FB-58341BA573A9Q30381595-5A1084A0-D7F9-45EC-BB01-E303764B8BC8Q30398516-FF24BADD-3227-4B23-87D7-24C705D39BA6Q30400584-09D57370-2F6A-4C4F-8714-60C6F5D76D32Q30402018-66550B24-42A4-4D98-AA71-9AD749136F1CQ30414712-C9B8744D-BC61-4BC6-A733-26EE66FF961DQ30419297-729EA4BA-9C1A-402B-A989-4E34E32B838EQ30421562-B2D30C48-63E2-41B9-8C14-8E2FA70041B2Q30424161-59315BA6-8108-468F-A04F-7BC8D0EE2C22Q30428833-81884D42-8BFF-4780-8498-63BE99EB0C2EQ36155151-5B2ECC40-50DC-42C1-B9CA-911B422592ACQ37254415-DCB41211-A68F-408E-B3E6-36E5773D7922Q41978537-5D2BE531-270F-41A9-8DF8-691F3C034E9CQ57170110-6602D27C-6779-41AE-B22C-85A1DF6FF65F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vaccinate before the next pandemic?
@ast
Vaccinate before the next pandemic?
@en
type
label
Vaccinate before the next pandemic?
@ast
Vaccinate before the next pandemic?
@en
prefLabel
Vaccinate before the next pandemic?
@ast
Vaccinate before the next pandemic?
@en
P356
P1433
P1476
Vaccinate before the next pandemic?
@en
P2093
Klaus Stöhr
P2860
P2888
P356
10.1038/465161A
P407
P577
2010-05-01T00:00:00Z
P6179
1021046472